CANNAINVESTOR Magazine Special Edition March / April 2019 | Page 71

35

Emerging Markets Report: At the Center of the Hemp Revolution

ORLANDO, FL / ACCESSWIRE / January 23, 2019 / Yesterday, Digipath Inc. (DIGP) broke news that they were going to open their proprietary potency-testing laboratories in North Carolina, Oregon, and Arizona at hemp production sites owned by Hemp, Inc.

In a cannabis world where hemp has now been given a legitimate seat at a massive table, Digipath's expansion is notable. It is important to note that a venerable player like Hemp, Inc. - which could go with anyone in the marketplace - chose Digipath as its testing provider. Digipath will also have the lucrative opportunity to reach out to other hemp farmers in the areas where Hemp Inc. currently has processing centers.

And most importantly, it shows even more penetration and progress for Digipath, which after cutting its teeth in the rapidly expanding Nevada market, will including the Hemp deal, have a presence in four states in 2019… Nevada, California, North Carolina, Oregon and Arizona.

Remember, our sister publication Small Cap Sentinel commented on Digipath's stated interest in Colombia last week which many believe will be one of the top cannabis producers in the world in short order. (Moreon that here. )

While time will tell as to the potential economic benefits to Digipath and its shareholders, adding operations in expanding markets and leveraging the savings of already proven technology is normally good for the proforma. Ultimately, Qs and K's will tell that story too.

But what is becoming quite obvious is that Digipath's years of refining their testing practices and operational team to create a durable template that can be replicated just about anywhere where hemp is sewn and grown gives the company the ability to participate in a significant way in the Hemp Revolution. Nearly every legal cannabis location requires similar state regulated testing that Digipath provides.

Editorial Room

For an Investor's Introduction to Digipath please visit https://bit.ly/2ALNzRR

Section 17(b) Disclosure of the Securities Act of 1933

http://emergingmarketsllc.com/disclaimer.php